CME Group
The 10-second takeaway
Comparing the upcoming quarter to the prior-year quarter, average analyst estimates predict CME Group's revenues will contract -4.9% and EPS will wither -5.7%.
The average estimate for revenue is $797.6 million. On the bottom line, the average EPS estimate is $0.83.
Revenue details
Last quarter, CME Group logged revenue of $774.6 million. GAAP reported sales were 6.9% lower than the prior-year quarter's $831.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS details
Last quarter, EPS came in at $0.80. GAAP EPS of $0.80 for Q1 were 41% lower than the prior-year quarter's $1.36 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
Recent performance
For the preceding quarter, gross margin was 79.9%, 260 basis points worse than the prior-year quarter. Operating margin was 58.2%, 480 basis points worse than the prior-year quarter. Net margin was 34.4%, 2,050 basis points worse than the prior-year quarter.
Looking ahead
The full year's average estimate for revenue is $3.14 billion. The average EPS estimate is $3.29.
Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 761 members rating the stock outperform and 50 members rating it underperform. Among 198 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 186 give CME Group a green thumbs-up, and 12 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on CME Group is outperform, with an average price target of $61.12.
Can your portfolio provide you with enough income to last through retirement? You'll need more than CME Group. Learn how to maximize your investment income and "Secure Your Future With 9 Rock-Solid Dividend Stocks." Click here for instant access to this free report.
- Add CME Group to My Watchlist.